WT1 and neoplasm: WT1 represents an ideal target for tumor-directed immunotherapy in EOC, as it is an oncofetal antigen with expression in normal adult tissues limited to kidney, ovary, testis, spleen, and mesothelial lining but with overexpression in EOC cells [23,24,25].